Intellia Therapeutics (NTLA)
(Delayed Data from NSDQ)
$21.46 USD
-0.92 (-4.11%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $21.44 -0.02 (-0.09%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -1.34 |
EPS Last Quarter | -1.31 |
Last EPS Surprise | -8.26% |
ABR | 1.54 |
Earnings ESP
|
-1.38% |
---|---|
Current Year | -5.15 |
Next Year | -5.26 |
EPS (TTM) | -5.21 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 13.83M | 13.93M | 82.23M | 87.86M |
# of Estimates | 9 | 9 | 13 | 11 |
High Estimate | 32.69M | 36.44M | 187.60M | 210.00M |
Low Estimate | 4.00M | 4.00M | 35.89M | 9.00M |
Year ago Sales | 11.99M | -1.92M | 36.28M | 82.23M |
Year over Year Growth Est. | 15.38% | 825.73% | 126.68% | 6.85% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.34 | -1.38 | -5.15 | -5.26 |
# of Estimates | 13 | 12 | 14 | 14 |
Most Recent Consensus | -1.26 | -1.29 | -5.23 | -6.03 |
High Estimate | -1.05 | -0.98 | -4.52 | -4.40 |
Low Estimate | -1.54 | -1.71 | -5.68 | -6.32 |
Year ago EPS | -1.38 | -1.46 | -5.42 | -5.15 |
Year over Year Growth Est. | 2.90% | 5.48% | 4.98% | -2.04% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 1 | 1 | 1 |
Down Last 7 Days | 1 | 1 | 2 | 2 |
Down Last 30 Days | 1 | 1 | 2 | 3 |
Down Last 60 Days | 1 | 1 | 2 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.34 | -1.38 | -5.15 | -5.26 |
7 Days Ago | -1.32 | -1.36 | -5.08 | -5.26 |
30 Days Ago | -1.32 | -1.36 | -5.08 | -5.26 |
60 Days Ago | -1.32 | -1.38 | -5.10 | -5.28 |
90 Days Ago | -1.34 | -1.39 | -5.18 | -5.31 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.36 | -1.38 | -5.52 | -5.26 |
Zacks Consensus Estimate | -1.34 | -1.38 | -5.15 | -5.26 |
Earnings ESP | -1.38% | 0.18% | -7.07% | -0.04% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.31 | -1.06 | -1.46 | -1.38 | NA |
Estimate | -1.21 | -1.35 | -1.47 | -1.52 | NA |
Difference | -0.10 | 0.29 | 0.01 | 0.14 | 0.09 |
Surprise | -8.26% | 21.48% | 0.68% | 9.21% | 5.78% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more